Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese

Pei Chieng Cha, Taisei Mushiroda, Atsushi Takahashi, Michiaki Kubo, Shiro Minami, Naoyuki Kamatani, Yusuke Nakamura

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Warfarin is a commonly used anticoagulant, whose dose needs to be determined for each individual patient owing to large inter-individual variability in its therapeutic dose. Although several clinical and genetic variables influencing warfarin dose have been identified, uncovering additional factors are critically important for safer use of warfarin. Through a genome-wide association study, we identified single-nucleotide polymorphism (SNP) rs2108622 [cytochrome P450, family 4, subfamily F, polypeptide 2 (CYP4F2)] as a genetic determinant of warfarin responsiveness for Japanese. Stratifying subjects who have been pre-classified according to the genotypes of SNP rs10509680 [cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9)] and SNP rs9923231 [vitamin K epoxide reductase complex subunit 1 (VKORC1)], based on their genotypes of rs2108622 allowed identification of subjects who require higher dose of warfarin. Incorporating genotypes of rs2108622 into a warfarin dosing algorithm that considers age, body surface area, status of amiodarone co-administration and genotypes of SNPs in the CYP2C9 and VKORC1 genes improved the model's predictability to 43.4%. In this study, the association of CYP4F2 with warfarin dose of the Japanese has been established for the first time. Besides, a warfarin dosing algorithm that incorporates genotypes of rs2108622 and amiodarone co-administration status was suggested for the Japanese. Our study also implied that common SNPs other than those in the CYP2C9, VKORC1 and CYP4F2 genes that show strong effect on the therapeutic warfarin dose might not exist.

Original languageEnglish
Pages (from-to)4735-4744
Number of pages10
JournalHuman molecular genetics
Volume19
Issue number23
DOIs
Publication statusPublished - 01-12-2010

Fingerprint

Genome-Wide Association Study
Warfarin
Vitamin K Epoxide Reductases
Single Nucleotide Polymorphism
Genotype
Amiodarone
Peptides
Body Surface Area
Therapeutic Uses
Anticoagulants
Genes

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Cha, P. C., Mushiroda, T., Takahashi, A., Kubo, M., Minami, S., Kamatani, N., & Nakamura, Y. (2010). Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese. Human molecular genetics, 19(23), 4735-4744. https://doi.org/10.1093/hmg/ddq389
Cha, Pei Chieng ; Mushiroda, Taisei ; Takahashi, Atsushi ; Kubo, Michiaki ; Minami, Shiro ; Kamatani, Naoyuki ; Nakamura, Yusuke. / Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese. In: Human molecular genetics. 2010 ; Vol. 19, No. 23. pp. 4735-4744.
@article{4cce0fbcded549d185a7ad012fbdfa78,
title = "Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese",
abstract = "Warfarin is a commonly used anticoagulant, whose dose needs to be determined for each individual patient owing to large inter-individual variability in its therapeutic dose. Although several clinical and genetic variables influencing warfarin dose have been identified, uncovering additional factors are critically important for safer use of warfarin. Through a genome-wide association study, we identified single-nucleotide polymorphism (SNP) rs2108622 [cytochrome P450, family 4, subfamily F, polypeptide 2 (CYP4F2)] as a genetic determinant of warfarin responsiveness for Japanese. Stratifying subjects who have been pre-classified according to the genotypes of SNP rs10509680 [cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9)] and SNP rs9923231 [vitamin K epoxide reductase complex subunit 1 (VKORC1)], based on their genotypes of rs2108622 allowed identification of subjects who require higher dose of warfarin. Incorporating genotypes of rs2108622 into a warfarin dosing algorithm that considers age, body surface area, status of amiodarone co-administration and genotypes of SNPs in the CYP2C9 and VKORC1 genes improved the model's predictability to 43.4{\%}. In this study, the association of CYP4F2 with warfarin dose of the Japanese has been established for the first time. Besides, a warfarin dosing algorithm that incorporates genotypes of rs2108622 and amiodarone co-administration status was suggested for the Japanese. Our study also implied that common SNPs other than those in the CYP2C9, VKORC1 and CYP4F2 genes that show strong effect on the therapeutic warfarin dose might not exist.",
author = "Cha, {Pei Chieng} and Taisei Mushiroda and Atsushi Takahashi and Michiaki Kubo and Shiro Minami and Naoyuki Kamatani and Yusuke Nakamura",
year = "2010",
month = "12",
day = "1",
doi = "10.1093/hmg/ddq389",
language = "English",
volume = "19",
pages = "4735--4744",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "23",

}

Cha, PC, Mushiroda, T, Takahashi, A, Kubo, M, Minami, S, Kamatani, N & Nakamura, Y 2010, 'Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese', Human molecular genetics, vol. 19, no. 23, pp. 4735-4744. https://doi.org/10.1093/hmg/ddq389

Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese. / Cha, Pei Chieng; Mushiroda, Taisei; Takahashi, Atsushi; Kubo, Michiaki; Minami, Shiro; Kamatani, Naoyuki; Nakamura, Yusuke.

In: Human molecular genetics, Vol. 19, No. 23, 01.12.2010, p. 4735-4744.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese

AU - Cha, Pei Chieng

AU - Mushiroda, Taisei

AU - Takahashi, Atsushi

AU - Kubo, Michiaki

AU - Minami, Shiro

AU - Kamatani, Naoyuki

AU - Nakamura, Yusuke

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Warfarin is a commonly used anticoagulant, whose dose needs to be determined for each individual patient owing to large inter-individual variability in its therapeutic dose. Although several clinical and genetic variables influencing warfarin dose have been identified, uncovering additional factors are critically important for safer use of warfarin. Through a genome-wide association study, we identified single-nucleotide polymorphism (SNP) rs2108622 [cytochrome P450, family 4, subfamily F, polypeptide 2 (CYP4F2)] as a genetic determinant of warfarin responsiveness for Japanese. Stratifying subjects who have been pre-classified according to the genotypes of SNP rs10509680 [cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9)] and SNP rs9923231 [vitamin K epoxide reductase complex subunit 1 (VKORC1)], based on their genotypes of rs2108622 allowed identification of subjects who require higher dose of warfarin. Incorporating genotypes of rs2108622 into a warfarin dosing algorithm that considers age, body surface area, status of amiodarone co-administration and genotypes of SNPs in the CYP2C9 and VKORC1 genes improved the model's predictability to 43.4%. In this study, the association of CYP4F2 with warfarin dose of the Japanese has been established for the first time. Besides, a warfarin dosing algorithm that incorporates genotypes of rs2108622 and amiodarone co-administration status was suggested for the Japanese. Our study also implied that common SNPs other than those in the CYP2C9, VKORC1 and CYP4F2 genes that show strong effect on the therapeutic warfarin dose might not exist.

AB - Warfarin is a commonly used anticoagulant, whose dose needs to be determined for each individual patient owing to large inter-individual variability in its therapeutic dose. Although several clinical and genetic variables influencing warfarin dose have been identified, uncovering additional factors are critically important for safer use of warfarin. Through a genome-wide association study, we identified single-nucleotide polymorphism (SNP) rs2108622 [cytochrome P450, family 4, subfamily F, polypeptide 2 (CYP4F2)] as a genetic determinant of warfarin responsiveness for Japanese. Stratifying subjects who have been pre-classified according to the genotypes of SNP rs10509680 [cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9)] and SNP rs9923231 [vitamin K epoxide reductase complex subunit 1 (VKORC1)], based on their genotypes of rs2108622 allowed identification of subjects who require higher dose of warfarin. Incorporating genotypes of rs2108622 into a warfarin dosing algorithm that considers age, body surface area, status of amiodarone co-administration and genotypes of SNPs in the CYP2C9 and VKORC1 genes improved the model's predictability to 43.4%. In this study, the association of CYP4F2 with warfarin dose of the Japanese has been established for the first time. Besides, a warfarin dosing algorithm that incorporates genotypes of rs2108622 and amiodarone co-administration status was suggested for the Japanese. Our study also implied that common SNPs other than those in the CYP2C9, VKORC1 and CYP4F2 genes that show strong effect on the therapeutic warfarin dose might not exist.

UR - http://www.scopus.com/inward/record.url?scp=78149256303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149256303&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddq389

DO - 10.1093/hmg/ddq389

M3 - Article

C2 - 20833655

AN - SCOPUS:78149256303

VL - 19

SP - 4735

EP - 4744

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 23

ER -